Anonymous ID: bfe646 Aug. 8, 2020, 11:23 a.m. No.10224411   🗄️.is đź”—kun   >>4546 >>4769 >>4777 >>4980

MAGIC71 USMC C-560 departed Spokane, WA Int'l Airport se

GRZLY39 USMC C-560 wn from Frankfort, KY-Capital City Airport after a ground stop

R1944 US Army G5 descending for Miami Int'l from NAS Jax-this is completion of rt

POLO47 USAF C-17 Globemaster from San Juan, PR-went in yesterday in front of a MAGMA flight-origin of Fargo, ND Hector Int'l Airport

Anonymous ID: bfe646 Aug. 8, 2020, 11:54 a.m. No.10224608   🗄️.is đź”—kun   >>4624 >>4853

Top Insider sales/buys week ending August 7th, 2020

 

Sale-Individual

Amazon, Inc sold by Jeff Bezos: $3.12b-August 3-4

https://www.finviz.com/insidertrading.ashx?oc=1043298&tc=7&b=2

 

Sale-Institutional

Dynatrace, Inc sold by Thoma Bravo: $875.79m-August 5

Dynatrace Inc offers software intelligence platform for the enterprise cloud. The Company has designed its software intelligence platform to allow customers to modernize and automate information technology (IT) operations. Its product Dynatrace is able to provide real-time actionable insights about the performance of customers’ entire software ecosystem by integrating high fidelity, Web-scale data mapping its dependencies in real-time, and analyzing them with an open, deterministic artificial intelligence (AI) engine. Dynatrace has designed to maximize flexibility and control of the rich monitoring data captured and analyzed by platform. In also provides updates and enhancements automatically on a monthly basis while allowing customers the flexibility and control to adhere to their own data security and sovereignty requirements. Number of employees : 2 243 people.

https://www.marketscreener.com/DYNATRACE-INC-63216144/company/

https://www.finviz.com/insidertrading.ashx?oc=1813487&tc=7&b=2

 

Buy-Individual

Rekor Systems, Inc bought by CEO: $7m-August 5

Rekor Systems Inc., formerly Novume Solutions, Inc., is a holding company. The Company is focused on the logistics of procuring critical human resources. The Company formed a platform that provides an array of services including strategic advisory, business capture support, teaming and staffing of skilled, non-skilled and cleared personnel, crisis and risk management, and traditional and digital media communications. The Company also provides training, consulting, coaching, and implementation tools that help individuals. The Company provides safety technology service fully integrated automated traffic safety enforcement solutions, parking enforcement citation collections, and mobile technology equipment solutions for public safety agencies. Number of employees : 472 people.

https://www.marketscreener.com/REKOR-SYSTEMS-INC-60635894/company/

https://www.finviz.com/insidertrading.ashx?oc=1169337&tc=1&b=2

 

Buy-Institutional

Allovir, Inc bought by F2 Ventures Ltd: $49.33m-August 3, reported the 6th

AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to restore immunity in patients with T cell deficiencies. The Company’s product pipeline includes Viralym-M (ALVR105), ALVR106, ALVR109, ALVR107 and ALVR108. Its lead product candidate, Viralym-M, is a multi-VST therapy targeting five viruses: BK virus (BKV), cytomegalovirus (CMV) adenovirus (AdV), Epstein-Barr virus (EBV), and human herpesvirus six (HHV-6). The ALVR106 is an allogeneic VST therapy developed to target diseases caused by four respiratory viruses: respiratory syncytial virus (RSV), influenza, parainfluenza virus (PIV), and human metapneumovirus (hMPV). LVR109 is an allogeneic VST therapy that targets severe acute respiratory syndrome coronavirus two (SARS-CoV-2).

https://www.marketscreener.com/ALLOVIR-INC-110325237/company/

Aug. 3, 2020

AlloVir Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

https://www.marketwatch.com/press-release/allovir-announces-closing-of-upsized-initial-public-offering-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares-2020-08-03-161973121

https://www.finviz.com/insidertrading.ashx?oc=1575745&tc=1&b=2